Zafirlukast
NDC 59651-292, Zafirlukast, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-292
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213163
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZAFIRLUKAST20 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inhibitors [MoA]; Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-292-60 | 59651029260 | 60 TABLET, FILM COATED in 1 BOTTLE (59651-292-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8bdb47c5-9d19-4d59-94c8-62c117525e7fNADAC price for package 59651029260
GET /v1/drugs/nadac/59651029260
Use it
Look up 59651-292 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-292. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.